High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Inclusion Criteria

• •able to understand treatment protocol and informed consent form
• •estimated by the investigator to be compliant for study participation
• •confirmed breast cancer with an indication to undergo breast conserving surgery
• •confirmed prostate cancer with an indication to undergo resective surgeryprostatectomy;
• •confirmed thyroid lesion with an indication to undergo resective surgery;
• •confirmed parathyroid adenoma with an indication to undergo resective surgery;
• •suspected basal cell carcinoma, squamous cell carcinoma or melanoma with an indication to undergo resective surgery;
• •suspected lesion in genitourinary sites (including bladder cancer, renal pelvis and ureter carcinoma, adrenal cortical carcinoma and renal cell carcinoma) with an indication to undergo resective surgery;
• •suspected lesion in the head \& neck region with an indication to undergo resective surgery;
• •confirmed primary or secondary hepatobiliary cancer with an indication to undergo resective surgery;
• •patients undergoing biopsy after metabolic active lesions were detected on a PET scan.
• •suspected neuro-endocrine malignancies with an indication to undergo resective surgery.
• •suspected brain tumor with an indication to undergo resective surgery.
• •Suspected malignant and benign gastrointestinal lesions with an indication to undergo resective surgery.
• •suspected malignant thoracovascular lesions with an indication to undergo resective surgery